Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis

Hepato-Gastroenterology

Volumn 57, Issue 104, 2010, Pages 1442-1444

  Ajduković, Jasna ^a   Tonkić, Ante ^b   Salamunić, Ilza ^b   Hozo, Izet ^b   Šimunić, Miroslav ^b   Bonacin, Damir ^b  

^a General Practice ^*  (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

IL 33 human; Immunity, mucosal; Interleukin 17 17A; Interleukins; Ulcerative colitis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 33;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ASSAY; ULCERATIVE COLITIS;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKINS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 79952435375     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology. 2009;136:1182-1197.
2. Tsianos EV, Katsanos K. Do we really understand what the immunological disturbances in inflammatory bowel disease mean? World J Gastroenterol. 2009;15:521-525.
3. Mayer L. Current concept of inflammatory bowel disease: etiology and patogenesis. In: Kirsner JB, ed. Inflammatory Bowel Disease. Philadelphia, PA: W. B. Saunders Company; 2000:280-292.
4. Macfarlane S, Steed H, Macfarlane GT. Intestinal bacteria and inflammatory bowel disease. Crit Rev Clin Lab Sci. 2009;46:25-54.
5. Boden EK, Snapper SB. Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol. 2008;24:733-741.
6. Elson CO. The immunology of inflammatory bowel disease. In: Kirsner JB, ed. Inflammatory Bowel Disease. Philadelphia, PA: W.B. Saunders Company; 2000:208-231.
7. Podolsky DK, Fiocchi C. Cytokines, chemokines, growth factors, eicosanoids and other bioactive molecules in inflammatory bowel disease. In: Kirsner JB, ed. Inflammatory Bowel Disease. Philadelphia, PA: W.B. Saunders Company; 2000:191-202.
8. Gadina M, Jefferies CA. IL-33: a sheep in wolfs clothing? Sci STKE. 2007(390):pe31.
9. Hayakawa H, Hayakawa M, Kume A, et al. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007;282:26369-26380. (Pubitemid 47443815)
10. Allakhverdi Z, Smith DE, Comeau MR, et al. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol. 2007;179:2051-2054.
11. Iikura M, Suto H, Kajiwara N, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 2007;87:971-978. (Pubitemid 47429189)
12. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One. 2008;3:e3331.
13. Zhou L, Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967-974. (Pubitemid 47300011)
14. Ivanov S, Lindén A. Interleukin-17 as a drug target in human disease. Trends Pharmacol Sci. 2009;30:95-103.
15. Chang SH, Dong C. IL-17F: regulation, signaling and function in inflammation. Cytokine. 2009;46:7-11.
16. Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol. 2009;123:1004-11.
17. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol. 2008;180:5625-5635.
18. Carriere V, Roussel L, Ortega N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA. 2007;104:282-287. (Pubitemid 46068023)
19. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52:65-70. (Pubitemid 36020767)